Detection of EBV DNA among patients with no current, prior, or subsequent EBV+ disease
| Diagnosis . | # of patients . | EBV DNA detected in plasma n (%) . | EBV DNA detected in PBMCs n (%) . | Median EBV DNA copies/mL plasma (range) . | Median EBV DNA copies/105 PBMCs (range) . |
|---|---|---|---|---|---|
| No EBV disease | 2004 | 121 (6) | 366 (18) | 0 (0-328 630) | 0 (0-76 414) |
| Immunocompetent | 808 | 28 (3) | 90 (11) | 0 (0-9966) | 0 (0-66 617) |
| Transplant recipient | 680 | 49 (7) | 161 (24) | 0 (0-328 630) | 0 (0-76 414) |
| On pharmacologic immunosuppression | 312 | 14 (4) | 37 (12) | 0 (0-3600) | 0 (0-2789) |
| HIV-infected | 178 | 29 (16) | 78 (44) | 0 (0-167 450) | 132 (0-34 433) |
| Primary immunodeficiency | 26 | 1 (4) | 0 (0) | 0 (0-70) | 0 (0-0) |
| Diagnosis . | # of patients . | EBV DNA detected in plasma n (%) . | EBV DNA detected in PBMCs n (%) . | Median EBV DNA copies/mL plasma (range) . | Median EBV DNA copies/105 PBMCs (range) . |
|---|---|---|---|---|---|
| No EBV disease | 2004 | 121 (6) | 366 (18) | 0 (0-328 630) | 0 (0-76 414) |
| Immunocompetent | 808 | 28 (3) | 90 (11) | 0 (0-9966) | 0 (0-66 617) |
| Transplant recipient | 680 | 49 (7) | 161 (24) | 0 (0-328 630) | 0 (0-76 414) |
| On pharmacologic immunosuppression | 312 | 14 (4) | 37 (12) | 0 (0-3600) | 0 (0-2789) |
| HIV-infected | 178 | 29 (16) | 78 (44) | 0 (0-167 450) | 132 (0-34 433) |
| Primary immunodeficiency | 26 | 1 (4) | 0 (0) | 0 (0-70) | 0 (0-0) |